ANA 877 Antiarrhythmics Lecture

Introduction to Antiarrhythmics

  • Focus of the lecture: antiarrhythmics.

  • Reference materials: Stolting Chapter 21, Nagel Hout Chapter 13 for supplementary information.

  • Importance of understanding cardiac conduction and EKG interpretation to grasp antiarrhythmics.

Cardiac Conduction System

  • Overview of key components in the cardiac conduction system:

    • SA Node: initiates the impulse.

    • Internodal tracts: pathways for impulse propagation. Three key tracts:

    • Anterior internodal tract (Bachmann bundle)

    • Middle internodal tract (Winkiebach tract)

    • Posterior tract (Thurall tract)

    • AV Node: relays the impulse to the ventricles.

    • Bundle of His: transmits impulses from the AV node to the bundle branches.

    • Bundle branches: carry impulses to the ventricles.

    • Purkinje fibers: distribute impulses throughout the ventricles.

  • Arrangement of conduction pathways: SA node → 3 internodal tracts → AV node → Bundle of His → Bundle branches → Purkinje fibers.

Conduction Velocity

  • Definition: speed of electrochemical propagation along the neural pathway.

  • Influencing factors:

    • Resting membrane potential

    • Amplitude of action potential

    • Rate of change during phase zero

  • Influencing elements:

    • Autonomic tone

    • Electrolyte imbalances (hyperkalemia, acidosis)

    • Ischemia

    • Antiarrhythmic drugs.

  • Comparative speed of conduction:

    • SA and AV nodes: 0.020.100.02 - 0.10 m/s (relatively slow).

    • Myocardial muscle cells: 0.3-1m/sec (intermediate speed)

    • Bundle branches and Purkinje fibers: 1-4 m/sec (faster conduction.)

EKG and Cardiac Action Potential

  • Slide introduction to EKG components and mechanical events.

    • EKG: graphical representation of electrical activities of the heart.

  • Ventricular Action Potential:

    • Absolute refractory period: myocytes cannot be depolarized.

    • Relative refractory period: requires larger stimuli for depolarization.

    • KNOW DIAGRAM (HD monitoring APEX)

  • Wiggers Diagram: illustrates phases of the cardiac cycle, including:

    • Atrial and ventricular pressures.

    • Valves open and close at distinct times.

    • Heart volume changes during different phases: passive filling, active filling, diastasis.

Phases of the Cardiac Action Potential

  • Detailed breakdown of action potential phases:

    • Phase 0: Rapid depolarization (sodium influx).

    • Phase 1: Initial repolarization (chloride influx, potassium efflux).

    • Phase 2: Plateau (calcium influx, continued potassium efflux).

    • Phase 3: Final repolarization (potassium efflux).

    • Phase 4: Resting phase (gradual potassium leak).

  • Important EKG events correlating with action potential phases are crucial for understanding arrhythmias.

Discussion of EKG Disturbances

  • Common EKG disturbances and rhythms:

    • Bradycardia: heart rate < 60 bpm.

    • Tachycardia: heart rate > 100 bpm.

    • Atrial fibrillation, atrial flutter, junctional rhythms, PVCs.

    • Complications: ventricular fibrillation and its implications.

Proarrhythmic Effects

  • Potential side effects of medications that can cause arrhythmias (proarrhythmias):

    • Example: Torsades de Pointes (Torsades)

    • Can arise from QTc prolongation.

    • Drugs that cause QT prolongation include class 1A antiarrhythmics, certain antibiotics (e.g., Zofran).

    • Incessant Ventricular Tachycardia (V tach):

    • Caused by slowed conduction, particularly with class 1A and 1C drugs.

    • Reentrant tachycardia circuit requires medication or external shock to interrupt.

Heart Block Review

  • Normal PR interval: 0.100.200.10 - 0.20 seconds.

  • First-degree heart block: Prolonged PR interval (stable, common in elderly).

  • Second-degree heart block types:

    • Mobitz Type I (Wenckebach): progressive PR interval lengthening leading to a dropped beat.

    • Mobitz Type II: intermittent non-conducted beats often requiring intervention.

  • Third-degree heart block (complete heart block): independent atrial and ventricular rates (AV dissociation).

Antiarrhythmic Medications Overview

  • Classification of antiarrhythmics based on ion channel blockade:

    • Class I: Sodium channel blockers (subdivided into Ia, Ib, Ic).

    • Ia: Lengthens action potential duration (e.g., quinidine, procainamide).

    • Ib: Shortens action potential duration (e.g., lidocaine, mexiletine).

    • Ic: Potent sodium channel inhibitors (e.g., flecainide).

    • Class II: Beta blockers (e.g., propranolol, esmolol): decrease heart rate and myocardial oxygen demand.

    • Class III: Potassium channel blockers (e.g., amiodarone): prolong action potential duration.

    • Class IV: Calcium channel blockers (e.g., diltiazem, verapamil): slow conduction and decrease heart rate.

Specific Antiarrhythmic Drugs

  • Lidocaine: Used for ventricular arrhythmias (e.g., PVCs, V tach).

    • Mechanism: Delays phase 4 depolarization.

    • Dosage: 2extmg/kg2 ext{ mg/kg} bolus, therapeutic levels 15extmcg/ml1 - 5 ext{ mcg/ml}.

    • Advantages: Rapid onset, low side effect profile.

  • Beta Blockers:

    • Propranolol: non-selective beta blocker, hepatic metabolism, dosage varies.

    • Esmolol: selective beta blocker, rapid onset, short duration of action (101510-15 mins), careful with concurrent beta blocks.

    • Effects: Reduces heart rate, myocardial oxygen demand.

  • Amiodarone: Multifaceted antiarrhythmic, used for various tachyarrhythmias.

    • Dosage: Initial 300extmg300 ext{ mg} bolus; possible hypotension.

    • Side effects: Bradycardia, QT prolongation, pulmonary toxicity, thyroid dysfunction.

    • Reduces mortality rates post-MI.

  • Calcium Channel Blockers (e.g., Verapamil, Diltiazem): Best for rate control in rapid atrial arrhythmias.

    • Dosing of Diltiazem: 20extmgIV20 ext{ mg IV}; initiate drip thereafter.

    • Side effects: Bradycardia, hypotension, myocardial depression.

  • Digitalis (Digoxin): Used to stabilize atrial rhythms, slowing AV conduction.

    • Recognizable toxicity signs: atrial arrhythmias, visual disturbances.

  • Adenosine: Treats paroxysmal SVT, rapid infusion required.

    • Dose: Initial 6extmg6 ext{ mg}, followed by 612extmg6-12 ext{ mg} as needed.

    • Short half-life (10extseconds10 ext{ seconds}), side effects include transient heart block.